From July 1, 2022 to September 30, 2022, the company has repurchased 30,000 shares, representing 0.09% for KRW 461 million. With this, the company has completed the repurchase of 1,638,038 shares, representing 4.63% for KRW 27,613.64 million under the buyback announced on March 24, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,430 KRW | -2.49% | +13.26% | -17.17% |
2023 | Access Bio, Inc. acquired an unknown minority stake in CuraPatient Inc. | CI |
2023 | Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022. | CI |
1st Jan change | Capi. | |
---|---|---|
-17.17% | 191M | |
-4.67% | 12.33B | |
-5.19% | 8.14B | |
+28.82% | 5.62B | |
-8.09% | 4.24B | |
-55.43% | 3.06B | |
+13.49% | 2.76B | |
-1.34% | 2.41B | |
+32.76% | 2.23B | |
-3.55% | 1.87B |
- Stock Market
- Equities
- A950130 Stock
- News Access Bio, Inc.
- Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.